Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.
Cohen AT, Wallenhorst C, Rivera M, Ay C, Schaefer B, Abdelgawwad K, Psaroudakis G, Brobert G, Ekbom A, Lee AYY, Khorana AA, Becattini C, Carrier M, Coleman CI, Martinez C.
Cohen AT, et al. Among authors: martinez c.
Thromb Haemost. 2024 Apr 8. doi: 10.1055/a-2259-0662. Online ahead of print.
Thromb Haemost. 2024.
PMID: 38301711
Free article.